ADIPOQ and obesity due to melanocortin 4 receptor deficiency: On the contrary, adiponectin has anti-inflammatory and immune-regulatory effects, but its plasma levels are significantly reduced in obesity, weakening its anti-inflammatory effects and leading to worsened chronic low-grade inflammation and metabolic disorders [87].